Local Breast Cancer Recurrence Was Found During BioZorb Surveillance
This breast cancer diagnosis at a glance
- Subtype
- Invasive Ductal Carcinoma
- Biomarkers
- Initial right breast tumor: ER-positive, PR-positive, HER2-equivocal. Recurrent right breast tumor: ER-positive, PR-positive, HER2-negative.
- Sex
- Female
- Treatment
- surgery, radiation and surveillance
- Outcome
- Care Ongoing
Treatment course, step by step
- Right breast lumpectomy with BioZorb placement and negative sentinel-node biopsy was performed for the initial invasive ductal carcinoma.
- Postoperative radiation was completed.
- Six-month imaging surveillance continued for three years.
- Biopsy of a new 3 mm mass confirmed ER-positive, PR-positive, HER2-negative invasive ductal carcinoma.
- MRI and stereotactic biopsy found an additional right-breast disease site.
- Right mastectomy was performed for the recurrent disease.
What happened, in summary
A 75-year-old woman had previously received breast-conserving treatment for left ductal carcinoma in situ. Three years later, annual imaging of the opposite breast found a 6 mm irregular mass at the 1 o’clock position of the right breast. Biopsy showed grade II invasive ductal carcinoma that was ER-positive, PR-positive, and HER2-equivocal.
She underwent right lumpectomy with placement of a BioZorb marker, and sentinel-node biopsy was negative. Postoperative radiation followed, with imaging surveillance every six months.
Three years after right lumpectomy, mammography and ultrasound identified a new 3 mm mass medial to the BioZorb site. Biopsy confirmed grade II invasive ductal carcinoma that remained ER-positive and PR-positive and was HER2-negative. A separate asymmetry behind the BioZorb could not be fully assessed by ultrasound because of shadowing from the device and scar tissue. MRI showed a suspicious 2.0 cm mass in that region, and stereotactic biopsy confirmed another site of disease.
With recurrent cancer documented at two sites in the right breast, she underwent right mastectomy. The structured record centers on the right invasive cancer and recurrence; the earlier left DCIS is included only as clinical context.
Where this story comes from
This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full
How we source and attribute stories Accuracy and limitations
Collections this story belongs to
- ER Positive Breast Cancer 242 stories
- Lumpectomy for Breast Cancer 208 stories
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer